Results 91 to 100 of about 4,144,457 (271)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Pseudoaneurysm after arthroscopic procedure in the knee

open access: yesRevista Brasileira de Ortopedia, 2015
The aim of this study was to review all cases of pseudoaneurysm in the literature, in predominantly arthroscopic procedures on the knee, and to report on a case of pseudoaneurysm that we treated.
Edmar Stieven Filho   +5 more
doaj   +1 more source

The promised territories: the production of branded housing projects in contemporary Turkey [PDF]

open access: yes, 2016
Cities in Turkey, following the neoliberal restructuring of the country, have undergone a process of transformation in the last decade at a greater pace than experienced in previous periods.
Serin, Bilge
core   +3 more sources

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Assessment of genetically modified cotton T304‐40 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2024‐23010)

open access: yesEFSA Journal
Following the submission of dossier GMFF‐2024‐23010 Regulation (EC) No 1829/2003 from BASF Agricultural Solutions Seed US LLC, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk ...
EFSA Panel on Genetically Modified Organisms (GMO)   +20 more
doaj   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Assessment of genetically modified maize NK603 × T25 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21252)

open access: yesEFSA Journal
Following the submission of dossier GMFF‐2023‐21252 under Regulation (EC) No 1829/2003 from Bayer CropScience LP, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the ...
EFSA Panel on Genetically Modified Organisms (GMO)   +19 more
doaj   +1 more source

Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices [PDF]

open access: yes, 2019
Background: The rising number of patients with a left ventricular assist device (LVAD) require care management to successfully transition home after implantation. These patients and their families need to manage their heart failure, and the complexities
Hirschman, Karen   +3 more
core   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Assessment of genetically modified soybean MON 87705 for renewal authorisation under Regulation (EC) No 1829/2003 (application GMFF‐2023‐21236)

open access: yesEFSA Journal
Following the submission of application GMFF‐2023‐21236 under Regulation (EC) No 1829/2003 from Bayer CropScience LP, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on ...
EFSA Panel on Genetically Modified Organisms (GMO)   +24 more
doaj   +1 more source

Home - About - Disclaimer - Privacy